GASTROOESOPHAGEAL REFLUX DISEASE

This adverse event was reported 80580 times

These drugs are most commonly taken by patients reporting GASTROOESOPHAGEAL REFLUX DISEASE:

# Drug Count
0 ESOMEPRAZOLE MAGNESIUM 12006
1 OMEPRAZOLE MAGNESIUM 9374
2 PREDNISONE 5994
3 ERGOCALCIFEROL 5531
4 OMEPRAZOLE 5386
5 ASPIRIN 5093
6 ACETAMINOPHEN 4937
7 ASPIRIN 81 MG 4881
8 ASPIRIN 325 MG 4879
9 PANTOPRAZOLE 4754
See all common drugs associated with GASTROOESOPHAGEAL REFLUX DISEASE

GASTROOESOPHAGEAL REFLUX DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERGOCALCIFEROL 5531 0.1860
1 OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE 1357 0.1830
2 ALENDRONATE SODIUM AND CHOLECALCIFEROL 438 0.1580
3 NICOTINAMIDE 385 0.1507
4 BUPROPION HYDROBROMIDE 85 0.1473
5 FAMOTITINE 383 0.1301
6 12%AZELAIC ACID 102 0.1216
7 PSYLLIUM HUSK 157 0.1162
8 OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE 141 0.1133
9 AZATHIOPRINE SODIUM 271 0.1069
See all drugs enriched for association with GASTROOESOPHAGEAL REFLUX DISEASE

GASTROOESOPHAGEAL REFLUX DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1635 2.3765
1 Provitamin D2 Compound [EPC] 5531 0.1859
2 Guanylate Cyclase-C Agonist [EPC] 282 0.1359
3 CXC Chemokine Receptor 4 Antagonist [EPC] 1 0.1250
4 Bismuth [EPC] 315 0.0566
5 Interleukin-17A Antagonist [EPC] 1766 0.0474
6 Adrenocorticotropic Hormone [EPC] 38 0.0425
7 Cortisol Synthesis Inhibitor [EPC] 26 0.0344
8 Aluminum Complex [EPC] 771 0.0319
9 Sucrose-specific Enzyme [EPC] 5 0.0276
See all drug classes enriched for association with GASTROOESOPHAGEAL REFLUX DISEASE